A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

A medical director of liver transplants in Colorado says he has noticed a worrying rise in the number of young people in ...

As the non-alcoholic beverage market continues to grow, there are a wider variety of options to enjoy at home or at your ...

Excessive drinking not only impacts young adults' physical health the following day, but also their emotional wellness, new ...

It’s possible that GLP-1s may be useful for a range of substance use disorders, including opioid use disorder and nicotine ...

Drink responsibly” messages have not stopped risky drinking. Some say we need cancer warnings on wine bottles and beer cans ...

A small study confirms observations what users have observed: the medications reduce their cravings for alcohol.

Weekly treatment with low doses of the GLP-1 receptor agonist semaglutide (Ozempic) reduced alcohol consumption and craving ...

The blockbuster drug semaglutide, better known as Ozempic for diabetes and Wegovy for obesity, could also help people cut ...

A recent study published in JAMA Psychiatry revealed that Ozempic (semaglutide), a medication commonly used for type 2 ...

Results of a placebo-controlled trial support prior observational findings that GLP-1 agonists can help reduce alcohol ...

A growing number of young Americans are drinking their way onto the organ transplant list — particularly women.